Superworth

Orion revenue OEC

Sales by quarter and over the last twelve months, from 2018.

Last 12 months, to Jun 30, 2026
$1.8B
Latest quarter, Q2 FY26
$500.9M
+7% on a year earlier
Fiscal year 2025
$1.8B
−4% on the year before

Orion's revenue was $1.8B over the twelve months to Jun 30, 2026, down 1% on a year earlier.

In its latest quarter, Q2 FY26, it was $500.9M, up 7% on the same quarter a year before.

Over the five fiscal years to FY2025 it grew 10% a year on average.

Revenue over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearRevenueChange
FY2025$1.8B−4%
FY2024$1.9B−1%
FY2023$1.9B−7%
FY2022$2B+31%
FY2021$1.5B+36%
FY2020$1.1B−23%
FY2019$1.5B−6%
FY2018$1.6Bn/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedRevenueOn a year earlierLast 12 months
Q2 FY26$500.9M+7%$1.8B
Q1 FY26$459.5M−4%$1.8B
Q4 FY25$411.7M−5%$1.8B
Q3 FY25$450.9M−3%$1.8B
Q2 FY25$466.4M−2%$1.8B
Q1 FY25$477.7M−5%$1.9B
Q4 FY24$434.2M−7%$1.9B
Q3 FY24$463.4M−1%$1.9B
Q2 FY24$477M+4%$1.9B
Q1 FY24$502.9M+0%$1.9B
Q4 FY23$468.2M+1%$1.9B
Q3 FY23$466.2M−14%$1.9B

Against its peers

Companies in Chemicals nearest Orion's size, closest first, today.

CompanyRevenue, 12 monthsGrowth
OECOrion$1.8B−1% a year
NAGENiagen Bioscience$129.1M+11% a year
FTKFlotek Industries$293M+37% a year
FTLFFitlife Brands$101.3M+61% a year
CRONCronos$179.1M+37% a year
ROGRogers$834.8M+5% a year
NGVTIngevity$1.2B−4% a year
IOSPInnospec$1.8B+3% a year
BTMDbiote$183.5M−8% a year
FULFuller H B$3.6B+1% a year
WDFCWD 40$674.7M+10% a year
Peer median$483.8M

Where Orion ranks

What the revenue tells you

Total sales in the period. On the company page, quarterly bars or the trailing twelve months (TTM), which smooths seasonality.

Growing revenue with shrinking margins is a warning, not a win.

More on Orion

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.